Testicular Cancer Conference Indianapolis 2026
October 8-10, 2026
Presented by fennec pharmaceuticals
Bringing Survivors, Patients, Caregivers, and Medical Experts Together
We are focused on bringing an international group of TC patients, survivors, and their loved ones together to address the physical and emotional toll of being diagnosed and treated for testicular cancer. We discuss life with and after cancer, and lifestyle changes that can help the healing process. We invite a panel of medical experts to provide pertinent information for patients currently fighting and resources for long-term survivorship. TCAF provides attendees with information and resources to advocate within their community about the importance of early detection.
OUR LEAD CHAIR FOR TCC INDIANAPOLIS 2026…
Nabil Adra, MD, MS
Dr. Nabil Adra is an Associate Professor of Clinical Medicine and Urology at Indiana University Simon Comprehensive Cancer Center. Dr. Adra is the program leader for Genitourinary Oncology at IU Simon Cancer Center and serves as service line leader for medical oncology and medical co-director of the IU Health Simon Cancer Center. His research focus is on novel therapeutics and biomarkers in testicular, prostate, and bladder cancer.
OUR EMCEE FOR TCC INDIANAPOLIS 2026…
BJ Lange
Survivor & TCAF Board Member
Retired USAF Medic, Hollywood Actor
BJ Lange is an Actor, 2X Testicular Cancer Survivor, & TCAF Board Member. Seen on MTV, General Hospital and The Rookie, BJ is a graduate of The Second City, where he is now an instructor. He is also an alumnus of iO West and UCBTLA, and a member of Warriors for Peace Theatre – a veteran Shakespeare Company. He’s a proud member of SAG-AFTRA and Actor's Equity. Off the screen and stage, BJ uses his experience as a retired USAF medic as a clinical instructor at UCLA's Center for Prehospital Care at the David Geffen School of Medicine Department of Emergency Medicine. Connect and watch BJ follow his dreams at BJLange.com
Guest Speakers & Topics to be determined
hotel to be determined
SPONSORS
We greatly appreciate our sponsors for helping make a positive impact in the fight against this disease and supporting this year’s Testicular Cancer Conference.
Thank You to Our Title Sponsor:
Fennec Pharmaceuticals is a biotechnology company dedicated to improving the lives of adolescent and young adult testicular cancer patients by helping reduce the risk of treatment-related hearing loss.
thank you to our diamond sponsor:
Natera™ is a global leader in cell-free DNA testing, providing personalized molecular residual disease (MRD) testing to help monitor for cancer recurrence and treatment response. Our oncology solutions are designed to empower patients and their care teams with timely, actionable information to support confident decision-making.
THANK YOU TO OUR SILVER SPONSORS:
Xencor is expanding the therapeutic boundaries of antibody drugs. Powered by its XmAb® protein engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat patients with cancer and other serious diseases.
The JDS Foundation’s mission is to enhance the life of those undergoing cancer treatment and to help create happy memories for patients and families. This is achieved by funding, planning, and advocating for worthwhile experiences. The foundation also values increasing knowledge and research regarding Primary Mediastinal Germ Cell Cancer and other Germ Cell Cancers.
It aims to assist with clinical trial information, travel costs for treatment, and mentorship support for patients.